An aerosol generating device includes: a liquid storage configured to store a liquid material; an aerosol generating space configured to accommodate a solid material including a tobacco material and a foamable material such that an aerosol is generated as the solid material comes in contact with the liquid material in the aerosol generating space; a liquid transfer tube connected to the liquid storage and the aerosol generating space such that the liquid material moves from the liquid storage to the aerosol generating space; and a mouthpiece configured to discharge the aerosol generated in the aerosol generating space, according to a user's inhalation.

A method of reducing nicotine cravings is described. The method includes inhalation of a dry powder formulation containing a dose of nicotine by a subject seeking nicotine cravings reduction. The formulation includes amounts and concentrations of nicotine that are significantly lower than cigarettes or nicotine replacement therapies.

A method of reducing nicotine cravings is described. The method includes inhalation of a dry powder formulation containing a dose of nicotine by a subject seeking nicotine cravings reduction. The formulation includes amounts and concentrations of nicotine that are significantly lower than cigarettes or nicotine replacement therapies.

The present invention improves and enhances the delivery of one of an aerosolized or micellized formula by use of an aerosol pressurized inhalation delivery device. The device may include one or more replaceable or reusable components, including but not limited to a canister and a battery. Methods for using the device to deliver a controlled dosage via the delivery device are also described herein.

The present invention improves and enhances the delivery of one of an aerosolized or micellized formula by use of an aerosol pressurized inhalation delivery device. The device may include one or more replaceable or reusable components, including but not limited to a canister and a battery. Methods for using the device to deliver a controlled dosage via the delivery device are also described herein.

Devices, systems and methods are provided for delivering coffee-derived volatiles to a user, particularly for the treatment of addiction. The coffee volatiles are selected and delivered by devices and systems which allow for concentrated delivery to the olfactory system of the user in a controlled manner. The olfactory system is the part of the sensory system used for smelling or olfaction. Olfaction of such coffee volatiles in this prescribed fashion stimulates the reward system of the brain such that a specific desired outcome is achieved. In some embodiments, the desired outcome is a reduction in addiction symptoms or curbing of a sensation of addiction withdrawal.

Devices, systems and methods are provided for delivering coffee-derived volatiles to a user, particularly for the treatment of addiction. The coffee volatiles are selected and delivered by devices and systems which allow for concentrated delivery to the olfactory system of the user in a controlled manner. The olfactory system is the part of the sensory system used for smelling or olfaction. Olfaction of such coffee volatiles in this prescribed fashion stimulates the reward system of the brain such that a specific desired outcome is achieved. In some embodiments, the desired outcome is a reduction in addiction symptoms or curbing of a sensation of addiction withdrawal.

An inhaler article includes a body extending along a longitudinal axis from a mouthpiece end to a distal end with an endpiece element at the distal end. A capsule cavity is defined within the body and extends along the longitudinal axis. A mouthpiece air channel extends from the capsule cavity to the mouthpiece end. A vortex tunnel is between the endpiece element and the capsule cavity. The vortex tunnel has an air inlet and an air passageway extending from the air inlet to the capsule cavity. The endpiece element is configured to restrict or prevent airflow through the distal end to the capsule cavity and the air inlet and air passageway of the vortex tunnel are configured to enable air to be drawn into the capsule cavity and form a vortex of inhalation air through the capsule cavity.

An inhaler article includes a body extending along a longitudinal axis from a mouthpiece end to a distal end with an endpiece element at the distal end. A capsule cavity is defined within the body and extends along the longitudinal axis. A mouthpiece air channel extends from the capsule cavity to the mouthpiece end. A vortex tunnel is between the endpiece element and the capsule cavity. The vortex tunnel has an air inlet and an air passageway extending from the air inlet to the capsule cavity. The endpiece element is configured to restrict or prevent airflow through the distal end to the capsule cavity and the air inlet and air passageway of the vortex tunnel are configured to enable air to be drawn into the capsule cavity and form a vortex of inhalation air through the capsule cavity.

An inhaler article includes a body (110) extending along a longitudinal axis from a mouthpiece (112) end to a distal end with an endpiece element at the distal end (114). A capsule cavity is defined within the body. An air inlet region is between the endpiece element (120) and the capsule cavity (116). A composite porous support element (140) defines a downstream end of the capsule cavity. The composite porous support element is formed of a first porous material concentrically disposed about a second porous material. The first porous material has a first resistance to draw and the second porous material having a second resistance to draw. The first resistance to draw is different than the second resistance to draw. A mouthpiece air channel (113) extends from the capsule cavity, through the composite porous element to the mouthpiece end.